[Federal Register Volume 87, Number 93 (Friday, May 13, 2022)]
[Notices]
[Pages 29382-29383]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-10244]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical Technology Enterprise Consortium

    Notice is hereby given that, on April 14, 2022, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Medical Technology Enterprise 
Consortium (``MTEC'') has filed written notifications simultaneously 
with the Attorney General and the Federal Trade Commission disclosing 
changes in its membership. The notifications were filed for the purpose 
of extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, Acenxion Biosystems, Inc., Kansas City, KS; Advanced 
Functional Fabrics of America, Inc., Cambridge, MA; American Type 
Culture Collection, Manassas, VA; ApnoMed, Inc., Bellevue, WA; Arete 
Associates, Northridge, CA; Asayena, La Jolla, CA; Aspisafe Solutions, 
Inc., Brooklyn, NY; Atmospheric Plasma Solutions, Cary, NC; Avel eCare 
LLC, Sioux Falls, SD; Avocado Labs Inc., Dallas, TX; Baylor University, 
Waco, TX; Bennett Federal LLC, Plymouth, MN; Blue Horizon Development 
LLC dba Precise Portions LLC, Norfolk, VA; Boston Engineering 
Corporation, Waltham, MA; Cambridge Research & Development, Inc., 
Nashua, NH; Capital Edge Consulting, Inc., McLean, VA; Caretaker 
Medical, Charlottesville, VA; Centre for Injury Studies London, UK; 
Chenega Reliable Services LLC, San Antonio, TX; Clemson University 
Research Foundation, Clemson, SC; CorNeat Vision Ltd., Raanana, ISR; D-
Prime LLC, McLean, VA; DxLab, Inc., Somerville, MA; Ejenta, Inc., San 
Francisco, CA; Enalare Therapeutics, Inc., Princeton, NJ; Excera, Inc., 
Minneapolis, MN; Fed Grow LLC dba FedNetix, Issaquah, WA; Federal 
Strategies LLC, Fredericksburg, VA; Frater GmbH, Naters, CH; GelSana 
Therapeutics, Inc., Aurora, CO; HAI Solutions, Inc., Santa Barbara, CA; 
Icahn School of Medicine at Mount Sinai, New York, NY; Ideal Medical 
Technologies, Inc., Asheville, NC; INdev LLC, Austin, TX; JAG 
Consulting LLC, Gulf Breeze, FL; JOHN J. RYAN (SEALING PRODUCTS) 
LIMITED, Dunboyne, IRE; Kunasan, Inc., Aurora, CO; Lactea Therapeutics 
LLC, Frederick, MD; LAINE Technologies, Goose Creek, SC; Leo Mora 
Therapy Services, PLLC, Killeen, TX; Limax Biosciences, Inc., 
Somerville, MA; Matregenix, Irvine, CA; MDC Studio, Inc., Baltimore, 
MD; MicroGEM US, Inc., Charlottesville, VA; Mid-America Applied 
Technologies Corporation, Chagrin Falls, OH; MLM Biologics, Inc., 
Gainesville, FL; Nakamir, Inc., Palo Alto, CA; Nanohmics, Inc., Austin, 
TX; Nanovatif Materials Technologies, Ankara, TUR; National Association 
of Veterans' Research and Education Foundations (NAVREF), Washington, 
DC; NowSecure, Inc., Vienna, VA; NuPeak Therapeutics, St Louis, MO; 
Obsidio, Inc., Columbia, SC; OneBreath, Inc., Palo Alto, CA; 
Organizational Performance Systems, Los Altos, CA; PALANQUINX PTY LTD, 
Hornsby Heights, AUS; Pascal Medical Corporation, Richmond, VA; PCCI, 
Inc., Alexandria, VA; PERSOWN, Inc., Jacksonville, FL; Quantumhave 
Ventura, Inc., San Jose, CA; Regranion LLC, Mt. Pleasant, SC; 
Repurposed Therapeutics, Inc. dba Defender Pharmaceuticals, Inc., Saint 
Louis, MO; Rock West Composites, Inc., San Diego, CA; SafetySpect, 
Inc., Grand Forks, ND; SanaHeal, Inc., Boston, MA; Scaled Microbiomics 
LLC, Hagerstown, MD; Selsym Biotech, Inc., Raleigh, NC; Sherpa 6, Inc., 
Littleton, CO; SISCAPA Assay Technologies, Inc., Washington, DC; 
Soliyarn, Belmont, MA; Sparta Biomedical, Inc., Chatham, NJ; SPEAR 
Human Performance, Inc., Sandy Springs, GA; SurgiBox, Cambridge, MA;

[[Page 29383]]

TechEn, Inc., Milford, MA; Technion Research and Development Foundation 
Ltd, Haifa, ISR; TetraCells, Inc., Marietta, GA; The University of 
Texas at Tyler, Tyler, TX; TrainXR LLC, Las Vegas, NV; University of 
Oregon, Eugene, OR; University of Texas Medical Branch at Galveston, 
Galveston, TX; University of Texas Permian Basin, Odessa, TX; 
University of Texas System, Austin, TX; Valtamer Oy, Helsinki, FIN; 
Vista LifeSciences, Inc. dba Vista Partners, Parker, CO; Vistendo, 
Inc., Arcadia, CA; War Horses for Veterans, Inc., Stilwell, KS; Wave 
Neuroscience, Inc., Newport Beach, CA; and Xomix Ltd, Chicago, IL, been 
added as parties to this venture.
    Also, Advancement Strategy LLC, Columbia, MD; Aktiv Pharma Group, 
Broomfield, CO; Alcamena Stem Cell Therapeutics LLC, Halethorpe, MD; 
Aldyn, Inc., Boston, MA; American Systems, Chantilly, VA; Arcos, Inc., 
Missouri City, TX; ARD Global LLC, McLean, VA; Avera Health, Sioux 
Falls, SD; Belle Artificial Intelligence Corporation, Cambridge, MA; 
Brainbox Solutions, Inc., Richmond, VA; Canvas Incorporated, 
Huntsville, AL; Capricor Therapeutics, Inc., Beverly Hills, CA; 
Carahsoft Technology Corporation, Reston, VA; Catharsis Productions, 
Chicago, IL; Cimarron Software Services, Inc., Houston, TX; Circadian 
Positioning Systems, Inc., Newport, RI; Cognosante, Falls Church, VA; 
Computer Technology Associates, Inc., Ridgecrest, CA; Dascena, Houston, 
TX; Delta Chase LLC, West Chester, OH; Dovel Technologies, McLean, VA; 
Dustoff Technologies LLC, Saint Augustine, FL; Exciton Technologies, 
Inc., Edmonton, Alberta, CAN; Expesicor, Inc., Missoula, MT; 
Exploration Institute, Cheyenne, WY; FesariusTherapeutics, Inc., 
Brooklyn, NY; Florida International University Board of Trustees, 
Miami, FL; FUJIFILM Pharmaceuticals USA, Inc., Valhalla, NY; GEN-AVIV 
LLC, North Miami Beach, FL; Georgia State University Research 
Foundation, Inc., Atlanta, GA; GreyScan, Inc., Melbourne, AUS; iGov 
Technologies, Inc., Tampa, FL; Kurve Technology, Inc., Lynnwood, WA; 
Luna Innovations Incorporated, Roanoke, VA; Martellus Pty, Ltd., 
Sydney, AUS; Maryland Development Center, Baltimore, MD; Navitas 
Business Consulting, Inc., Herndon, VA; Odyssey Systems Consulting 
Group, Ltd., Wakefield, MA; Opticyte, Inc., Seattle, WA; Parallax 
Advanced Research Corporation, Beavercreek, OH; Parnell 
Pharmaceuticals, Inc., San Rafael, CA; Pennsylvania State University, 
University Park, PA; PhAST Corp., Cambridge, MA; Phiex Technologies, 
Inc., Boston, MA; Plantiga Technologies, Inc., Vancouver, CAN; 
PreVeteran Group LLC, Jackson, WY; Rain Technologies LLC, Las Vegas, 
NV; Research Bridge Partners, Inc., Austin, TX; Retia Medical LLC, 
Valhalla, NY; Rhode Island Hospital, Providence, RI; RIVA Solutions, 
Inc., Mclean, VA; Rockland Technimed Limited, Mahwah, NJ; San Diego 
State University, San Diego, CA; SanMelix Laboratories, Inc., 
Hollywood, FL; Sentio Solutions, Inc., San Francisco, CA; Seventh 
Dimension LLC, Mocksville, NC; Sibel, Inc., Evanston, IL; SweetBio, 
Inc., Memphis, TN; Tagup, Inc., Somerville, MA; Think-Dragon LLC, 
Ellicott City, MD; Thornton Tomasetti, Inc., New York, NY; Throne 
Biotechnologies, Inc., Paramus, NJ; TITUS Sports Academy LLC, 
Tallahassee, FL; Turner Innovations, Orem, UT; University of New 
Hampshire, Durham, NH; VES LLC, Wilmington, OH; Virginia Commonwealth 
University, Richmond, VA; W.R. Joyce Incorporated, Michigan City, IN; 
ZIEN Medical Technologies, Inc., Salt Lake City, UT, has withdrawn as 
parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MTEC intends to file additional 
written notifications disclosing all changes in membership.
    On May 9, 2014, MTEC filed its original notification pursuant to 
Section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to Section 6(b) of the Act on June 9, 
2014 (79 FR 32999).
    The last notification was filed with the Department on February 4, 
2022. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on March 11, 2022 (87 FR 14041).

Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2022-10244 Filed 5-12-22; 8:45 am]
BILLING CODE P